about
CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher Disease.Glycomimetic-based pharmacological chaperones for lysosomal storage disorders: lessons from Gaucher, GM1-gangliosidosis and Fabry diseases.Delineating pathological pathways in a chemically induced mouse model of Gaucher disease.Pathological levels of glucosylceramide change the biophysical properties of artificial and cell membranes.
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Emerging therapeutic targets for Gaucher disease.
@en
type
label
Emerging therapeutic targets for Gaucher disease.
@en
prefLabel
Emerging therapeutic targets for Gaucher disease.
@en
P2093
P2860
P1476
Emerging therapeutic targets for Gaucher disease.
@en
P2093
Ayelet Vardi
Einat B Vitner
Timothy M Cox
P2860
P304
P356
10.1517/14728222.2014.981530
P407
P577
2014-11-21T00:00:00Z